Anticancer activity of new organo-ruthenium, rhodium and iridium complexes containing the 2-(pyridine-2-yl)thiazole N,N-chelating ligand

Michaël Gras, Bruno Therrien, Georg Süss-Fink, Angela Casini, Fabio Edafe, Paul J. Dyson

Research output: Contribution to journalArticlepeer-review

125 Scopus citations

Fingerprint

Dive into the research topics of 'Anticancer activity of new organo-ruthenium, rhodium and iridium complexes containing the 2-(pyridine-2-yl)thiazole N,N-chelating ligand'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Chemistry